4/A//SEC Filing
Horstmeier Paul 4/A
Accession 0001562180-22-003346
CIK 0001636422other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:36 PM ET
Size
15.4 KB
Accession
0001562180-22-003346
Insider Transaction Report
Form 4/AAmended
Horstmeier Paul
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-09$15.84/sh+521$8,253→ 196,877 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-09−4,166→ 39,569 totalExercise: $15.84Exp: 2029-02-05→ Common Stock (4,166 underlying) - Sale
Common Stock
2022-03-09$25.32/sh−20,526$519,665→ 180,517 total - Sale
Common Stock
2022-03-09$26.02/sh−201$5,229→ 180,316 total - Exercise/Conversion
Common Stock
2022-03-09$15.84/sh+4,166$65,989→ 201,043 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-09−521→ 6,248 totalExercise: $15.84Exp: 2029-02-05→ Common Stock (521 underlying)
Footnotes (6)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
- [F2]Due to a technical and administrative error, the original Form 4, filed on March 11, 2022, incorrectly included the sale of 2,482 shares of Common Stock by the Reporting Person that did not occur and was duplicative of the sale of such 2,482 shares of Common Stock that were previously reported.
- [F3]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.96, inclusive.
- [F4]Represents the weighted average sale price of the shares sold ranging from $26.00 to $26.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (3) and (4).
- [F5]25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
- [F6]25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001780978
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:36 PM ET
- Size
- 15.4 KB